Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%

Quarterly report 2023-Q1
added 05-15-2023

report update icon

Sorrento Therapeutics Financial Ratios 2011-2025 | SRNE

Annual Financial Ratios Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.4 -9.7 -1.8 -1.1 56.9 -4.3 -4.2 -7.8 -6.9 -14.7 -16.9

P/S

-4679.0 72.8 16.4 10.9 3.4 32.4 42.2 70.4 329.3 122.1 103.1

EPS

-1.4 -1.3 -2.2 -1.9 0.1 -1.2 -1.2 -1.3 -1.5 -0.0 -0.0

EV (Enterprise Value)

1.17 B 3.25 B 1.02 B 488 M 724 M 497 M 357 M 230 M 146 M 66.8 M 51.5 M

EBITDA per Share

-1.32 -0.859 -1.44 -1.19 0.775 -1.17 -1.32 -1.21 -0.989 -0.4 -0.311

EV/EBITDA

-3.0 -15.0 -3.8 -2.4 9.3 -3.9 -3.4 -6.5 -8.4 -14.5 -16.6

PEG

0.02 -0.24 0.12 0.0 0.51 -1.79 -0.92 -0.71 0.04 0.15 0.57

P/B

7.5 17.6 6.6 1.1 2.6 3.3 1.3 2.5 2.3 11.5 13.0

P/CF

-2.1 -14.8 -2.8 -1.9 -4.7 -3.4 -4.2 -9.2 -8.7 -16.4 -14.4

ROE %

-543.92 -180.72 -371.64 -97.17 4.58 -76.12 -31.56 -31.88 -32.80 -78.18 -76.89

ROA %

-61.65 -55.70 -52.38 -32.61 2.12 -15.17 -13.34 -24.49 -23.67 -71.45 -70.84

ROCE %

-509.79 -45.87 -44.12 -23.02 14.59 -18.40 -15.99 -26.16 -18.00 -78.30 -77.03

Current Ratio

1.1 0.9 0.6 2.9 0.4 1.2 4.6 7.7 6.0 9.0 9.9

DSO

-49566.1 141.5 168.5 75.1 9.4 133.7 208.2 69.9 312.7 49.9 42.2

DIO

- 67.2 100.3 - - - - - - - -

DPO

- 907.2 824.1 714.3 917.0 3727.4 250.6 295.9 177064.5 - -

Operating Cycle

-49566.1 208.8 268.8 75.1 9.4 133.7 208.2 69.9 312.7 - -

Cash Conversion Cycle

-49566.1 -698.4 -555.3 -639.3 -907.6 -3593.8 -42.4 -226.0 -176751.7 - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
2021202120202020201920192018201820172017201620162015201520142014201320132012201220112011180000 180000 120000 120000 60000 60000 0 0 -60000 -60000
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Sorrento Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.26 - -0.2 -0.54 -0.12 -0.47 -0.4 -0.57 0.01 -0.27 -0.33 -0.36 -0.36 -0.41 -0.49 -0.46 -0.88 -0.41 -0.4 -0.73 -0.38 0.6 -0.03 -0.2 -0.45 -0.3 0.24 -0.93 -0.41 -0.62 -0.03 -0.3 -0.29 -0.26 -0.27 -0.33 -0.44 - -0.24 -0.35 -0.2 - -0.1 -0.08 - - - - -

EBITDA per Share

-0.19 - -0.22 -0.28 -0.31 - -0.31 -0.33 -0.29 - -0.3 -0.19 -0.22 - -0.34 -0.36 -0.98 - -0.36 -0.24 -0.36 - 1.33 -0.15 -0.43 - -0.17 -0.94 -0.57 - -905 -0.25 -0.26 - -0.17 -254 -395 - -0.19 -0.33 -0.2 - -0.09 -0.07 - - - - -

ROE %

-186.29 -247.65 -431.04 -454.32 -382.51 -363.42 -223.32 -182.97 -140.20 -180.72 -217.36 -248.45 -273.60 -371.64 -315.47 -256.10 -219.13 -97.17 -49.13 -27.57 0.58 4.58 -42.01 -21.12 -68.12 -76.12 -72.13 -92.63 -46.07 -33.71 -23.21 -29.56 -29.79 -31.88 -29.08 -27.11 -52.13 -70.62 -148.80 -221.96 -267.34 -170.99 -187.67 -126.17 -73.83 -58.78 -16.68 -25.84 -16.26

ROA %

-94.17 -54.04 -74.83 -76.19 -62.87 -57.71 -50.27 -50.03 -43.14 -55.70 -53.62 -49.49 -45.16 -52.38 -49.09 -45.12 -46.77 -32.61 -13.41 -6.31 2.24 2.12 -13.56 -9.12 -16.62 -15.17 -18.47 -22.70 -15.10 -14.24 -12.51 -17.61 -20.39 -24.49 -22.10 -20.35 -38.05 -50.96 -122.41 -190.23 -238.01 -156.26 -171.63 -115.55 -67.91 -54.16 -15.37 -23.81 -14.98

ROCE %

-168.46 -217.44 -294.64 -288.84 -255.85 -168.17 -218.49 -191.61 -166.31 -105.36 -173.16 -190.64 -225.82 -288.61 -311.48 -266.55 -216.01 -51.95 -3.39 68.05 74.85 30.13 14.83 -49.04 -98.16 -98.67 -123.22 -132.47 -83.86 -38.82 -45.38 -27.39 -27.48 -22.99 -27.94 -26.33 -26.04 -15.77 -35.84 -50.95 -59.13 -49.95 -66.67 -63.32 -73.96 -58.89 -16.72 -25.88 -16.30

Current Ratio

0.8 1.0 1.3 1.3 1.4 1.1 1.2 1.3 1.6 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5 1.9 1.9 1.9 1.9 1.3 1.3 1.3 1.3 1.7 1.7 1.7 1.7 4.3 4.3 4.3 - - - - - - - - - - - - -

DSO

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 121.1 83.5 40.2 67.9 89.4 44.1 9.9 1.6 43.2 36.6 38.5 69.0 171.6 120.0 61.6 74.7 70.2 76.3 83.7 52.4 86.2 52.6 - 433.2 253.2 161.3 - - - - - - - -

DIO

- - - - - - - - - - - - - - - 93.5 123.8 - 121.5 215.7 100.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - 768.4 819.3 - 579.1 1028.4 825.8 - 833.5 1108.3 780.1 - 1808.0 2561.8 1222.7 - 202.3 389.1 268.5 - 286.7 296.3 308.7 - - - - - - - - - - - -

Operating Cycle

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 214.6 207.2 40.2 189.4 305.1 145.0 9.9 1.6 43.2 36.6 38.5 69.0 171.6 120.0 61.6 74.7 70.2 76.3 83.7 52.4 86.2 52.6 - 433.2 253.2 161.3 - - - - - - - -

Cash Conversion Cycle

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 -553.8 -612.1 40.2 -389.8 -723.3 -680.8 9.9 -831.9 -1065.1 -743.6 38.5 -1739.0 -2390.2 -1102.7 61.6 -127.6 -318.9 -192.1 83.7 -234.4 -210.1 -256.0 - 433.2 253.2 161.3 - - - - - - - -

All numbers in USD currency